Document is current
Any future updates will be listed below
-
Authors
Filser, Melanie
Buchner, Axel
Fink, Gereon Rudolf
Gold, Stefan M.
Penner, Iris-Katharina https://orcid.org/0000-0002-6746-1034
-
Funding
Funding for this research was provided by:
University of Bern
- License Information
-
More Information
Article History
Received: 21 May 2022
Revised: 27 August 2022
Accepted: 29 August 2022
First Online: 21 September 2022
Declarations
:
: Melanie Filser has no conflict of interest. Axel Buchner has no conflict of interest. Gereon R. Fink has no conflict of interest. Stefan M. Gold: Honoraria/speaker fees from Mylan, Almirall, and Celgene. Research grants from Biogen and kind support from the GAIA Group. Iris-Katharina Penner: Honoraria/speaker fees from Adamas Pharma, Almirall, Bayer Pharma, Biogen, BMS, Celgene, Desitin, Genzyme, Janssen, Merck, Roche, Novartis, and Teva. Research support from the German MS Society, Celgene, Teva, Roche, and Novartis. All listed potential conflicts of interest are outside the context of this article’s research, authorship, and publication.
